MedPath

Passive Versus Active Educational Interventions for Melanoma Recognition

Not Applicable
Completed
Conditions
Educational Problems
Melanoma (Skin)
Registration Number
NCT04507048
Lead Sponsor
Azienda Unità Sanitaria Locale Reggio Emilia
Brief Summary

This study evaluates the efficacy of a passive versus an active educational intervention in increasing the ability of laypersons at low risk for melanoma development, in recognizing atypical skin melanocytic lesions. Patients will be randomized (1:1) to receive the active or the passive intervention.

Detailed Description

Almost 60-70% of primary melanomas are first detected by patients or their relatives and not by physicians. Then, it appears imperative to promote public campaigns in order to increase the awareness of laypersons on the most important rules for early identification of atypical skin lesions. The two main clinical rules are:

1. ABCD rule. According to this rule, lesions characterized by one of more of the following features: Asymmetry, irregular Borders, Color variegation and Diameter larger than 6 mm, should be considered at risk for malignancy. In order to evaluate Evolution, monitoring strategies have been implemented;

2. "ugly duckling" sign. According to this rule, a suspicious lesion tends to be different from the general nevus pattern of a given patient.

The passive intervention will consist in the administration of a booklet containing the explanation of this two previous clinical rules for early detection of atypical melanocytic lesions. In the active intervention a standardized explanation will be given to the patient by a dermatologist, together with the administration of the booklet.

Efficacy will be evaluated through the completion of a specific test before, immediately after and after one month the administration of the educational intervention.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
560
Inclusion Criteria
  • no personal or family history for melanoma;
  • first visit for skin examination
Exclusion Criteria
  • patients referring to know and to be already confident in the use of at least one of the tested rules.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Rate of lesions correctly evaluated as at risk30 ± 2 days

Change at t1 and t2 from baseline (t0) in lesions at risk correctly identified, comparing passive and active educational intervention arms.

Secondary Outcome Measures
NameTimeMethod
Rate of lesions correctly assigned to the proper risk category30 ± 2 days

Change at t1 and t2 from baseline (t0) in lesions correctly assigned to the proper risk category (low, intermediate, high), comparing passive and active educational intervention arms.

Trial Locations

Locations (7)

Valeria Ciciarelli

🇮🇹

L'Aquila, AQ, Italy

Mariachiara Arisi

🇮🇹

Brescia, BS, Italy

Giovanni Pellacani

🇮🇹

Modena, MO, Italy

Caterina Longo

🇮🇹

Reggio Emilia, RE, Italy

Ketty Peris

🇮🇹

Rome, RM, Italy

Simone Ribero

🇮🇹

Turin, TO, Italy

Elvira Moscarella

🇮🇹

Naples, Italy

Valeria Ciciarelli
🇮🇹L'Aquila, AQ, Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.